Alignment Healthcare ALHC
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 92nd percentile, 5-year average -175.9x
#2620 of 2993 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 12th percentile, 5-year average 13.5x
#4484 of 5330 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 0th percentile, 5-year average 1.1x
#682 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 5.56 | – | 13.50 | 12% (cheaper than usual) | #4484 of 5330 (1 = cheapest) |
| PE | 54.12 | 642.43 | -175.93 | 92% (pricier than usual) | #2620 of 2993 (1 = cheapest) |
| PS | 0.31 | 0.25 | 1.10 | 0% (cheaper than usual) | #682 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ALHC.
Sign in to join the discussion.